Track topics on Twitter Track topics that are important to you
Bayer AG plans to cut its sales and profit forecasts for this year because of unexpectedly high stockpiling in Brazil of its crop-protection products. Full-year earnings before interest, taxes, depreciation and amortization and other special costs will be reduced by 300 million euros to 400 million euros, the Leverkusen, Germany-based company said in a The dimmer outlook comes even as the conglomerate forges ahead with its proposed $66 billion acquisition of Monsanto Co., the world's largest seed company.
Original Article: Bayer to Cut 2017 Forecasts as Crop Unit Struggles in BrazilNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...